Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living With Parkinson’s Disease
Cerevel Therapeutics在针对帕金森氏病患者的3期辅助试验中宣布Tavapadon的顶线结果呈阳性
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living With Parkinson’s Disease
Cerevel Therapeutics在针对帕金森氏病患者的3期辅助试验中宣布Tavapadon的顶线结果呈阳性
使用浏览器的分享功能,分享给你的好友吧